Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alanna McEneny-King, Alfonso Iorio, Gary Foster & Andrea N. Edginton. (2016) The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1313-1321.
Read now
Read now
Pia Petrini, Leonard A Valentino, Alessandro Gringeri, Wendy M Re & Bruce Ewenstein. (2015) Individualizing prophylaxis in hemophilia: a review. Expert Review of Hematology 8:2, pages 237-246.
Read now
Read now
Articles from other publishers (7)
Ting Zhou, Shuyue Wang, Yao Zhang, Runhui Wu & Hongchao Li. (2023) Cost‐effectiveness analysis of recombinant factor IX Fc fusion protein compared with recombinant factor IX for the treatment of moderate–severe to severe hemophilia B in China. Pediatric Blood & Cancer 70:6.
Crossref
Crossref
Irena Preloznik Zupan, Karla Rener & Sasa Anzej Doma. (2022) Treatment satisfaction and limitations in haemophilia A, with a focus on factor VIII product storage conditions: patients’ perspectives and challenges. Drugs & Therapy Perspectives 39:2, pages 71-80.
Crossref
Crossref
Jayashree Motwani, Benoit Guillet, Jan Blatny, Freimut H. Schilling, Bénédicte Wibaut, Jimena Goldstine, Andras Nagy, Jennifer Doralt, Werner Engl, Srilatha Tangada & Gerald Spotts. (2020) Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A. Haemophilia 26:3, pages 478-486.
Crossref
Crossref
Alanna McEneny-King, Pierre Chelle, Gary Foster, Arun Keepanasseril, Alfonso Iorio & Andrea N. Edginton. (2019) Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization. Journal of Pharmacokinetics and Pharmacodynamics 46:5, pages 411-426.
Crossref
Crossref
Alanna McEneny-King, Pierre Chelle, Severine Henrard, Cedric Hermans, Alfonso Iorio & Andrea Edginton. (2017) Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis. Pharmaceutics 9:4, pages 47.
Crossref
Crossref
Alanna McEneny-King, Gary Foster, Alfonso Iorio & Andrea N Edginton. (2016) Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo). JMIR Research Protocols 5:4, pages e232.
Crossref
Crossref
Bruno Neuner, Sylvia von Mackensen, Susanne Holzhauer, Stephanie Funk, Robert Klamroth, Karin Kurnik, Anne Krümpel, Susan Halimeh, Sarah Reinke, Michael Frühwald & Ulrike Nowak-Göttl. (2016) Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers. BioMed Research International 2016, pages 1-8.
Crossref
Crossref